The Measurement of Asthma and Allergic Rhinitis Control in Children and Adolescents.
adolescents
allergic rhinitis
asthma
children
control
Journal
Children (Basel, Switzerland)
ISSN: 2227-9067
Titre abrégé: Children (Basel)
Pays: Switzerland
ID NLM: 101648936
Informations de publication
Date de publication:
07 May 2020
07 May 2020
Historique:
received:
02
04
2020
revised:
15
04
2020
accepted:
29
04
2020
entrez:
13
5
2020
pubmed:
13
5
2020
medline:
13
5
2020
Statut:
epublish
Résumé
Asthma and allergic rhinitis (AR) are frequently associated. The objective of the treatment of asthma and AR should be the control of symptoms and disease progression. Therefore, the combined measurement of disease control is desirable. In this regard, a questionnaire able to together assess asthma and AR control has been validated: the CARAT (Control of Allergic Rhinitis and Asthma Test). A further pediatric version (CARATkids) has been generated. The current real-world study used different disease control measures in children and adolescents with asthma and rhinitis. A total of 138 children and adolescents were recruited at three allergy centers. CARAT, CARATkids, ACT (Asthma Control Test), cACT (children ACT), GINA (Global Initiative for Asthma) disease control classification, VAS (Visual Analog Scale) for asthma and nasal symptoms, and lung function were used in all subjects. There was a predominance of males (67.4%) and asthma was well-controlled (according to GINA classification) in about half the subjects. In children, the median CARAT and cACT values were 5 and 22 respectively. In adolescents, the median CARAT and ACT values were 23 for both tests. There were significant differences between CARAT and ACT (
Identifiants
pubmed: 32392738
pii: children7050043
doi: 10.3390/children7050043
pmc: PMC7278597
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Clin Transl Allergy. 2012 Aug 30;2(1):16
pubmed: 22935298
Ann Allergy Asthma Immunol. 2010 Feb;104(2):118-24
pubmed: 20306814
Methods Inf Med. 2019 Dec;58(S 02):e27-e42
pubmed: 31746447
Allergy. 2018 Jul;73(7):1369-1382
pubmed: 29178130
BMC Med Res Methodol. 2010 Mar 18;10:22
pubmed: 20298572
Pediatr Allergy Immunol. 2014 Mar;25(2):173-9
pubmed: 24628568
Rev Port Pneumol (2006). 2016 May-Jun;22(3):163-6
pubmed: 26767726
Med Sci (Basel). 2019 Mar 27;7(4):
pubmed: 30934800
N Engl J Med. 2016 Dec 8;375(23):2293-2297
pubmed: 27959688
Allergy. 2018 Dec;73(12):2381-2385
pubmed: 30028515
Curr Opin Allergy Clin Immunol. 2004 Jun;4(3):177-83
pubmed: 15126938
Ann Allergy Asthma Immunol. 2017 May;118(5):551-556.e2
pubmed: 28366584
Prim Care Respir J. 2013 Mar;22(1):112-6
pubmed: 23412110
Postgrad Med. 2015;127(7):738-43
pubmed: 26216491
Ann Allergy Asthma Immunol. 2016 Dec;117(6):725-727
pubmed: 27979030
Int Arch Allergy Immunol. 2019;178(4):333-337
pubmed: 30605899
Clin Exp Allergy. 2011 Jun;41(6):860-8
pubmed: 21518040
Pediatr Allergy Immunol. 2017 Mar;28(2):185-190
pubmed: 27801950
Pediatr Allergy Immunol. 2012 Sep;23(6):537-42
pubmed: 22625869
J Investig Allergol Clin Immunol. 2019 Jun;29(3):239-240
pubmed: 31219037
Clin Exp Allergy. 2017 Dec;47(12):1526-1533
pubmed: 28886234
J Asthma Allergy. 2020 Jan 30;13:67-75
pubmed: 32099412
Respir Res. 2009 Jun 17;10:52
pubmed: 19534774
Med Sci (Basel). 2019 Feb 11;7(2):
pubmed: 30754692
J Allergy Clin Immunol. 2020 Jan;145(1):70-80.e3
pubmed: 31627910
Curr Med Res Opin. 2011 Dec;27(12):2301-8
pubmed: 21988667
Allergy. 2010 Aug;65(8):1042-8
pubmed: 20121755
J Allergy Clin Immunol. 2007 Apr;119(4):817-25
pubmed: 17353040
Immunol Allergy Clin North Am. 2016 May;36(2):235-48
pubmed: 27083099
Respir Med. 2020 Feb;162:105858
pubmed: 31916535
BMC Pediatr. 2014 Feb 06;14:34
pubmed: 24502226